121 related articles for article (PubMed ID: 20080439)
1. A summary of the 25th International Papillomavirus Conference 2009: vaccines, screening, epidemiology and therapeutics.
Nicol AF; Nuovo GJ; Dillner J
J Clin Virol; 2010 Mar; 47(3):208-15. PubMed ID: 20080439
[TBL] [Abstract][Full Text] [Related]
2. Perspectives for the development of human papillomavirus vaccines and immunotherapy.
Bermúdez-Humarán LG; Langella P
Expert Rev Vaccines; 2010 Jan; 9(1):35-44. PubMed ID: 20021304
[TBL] [Abstract][Full Text] [Related]
3. Up to date: comprehensive knowledge of human papillomavirus.
Park JS; Hur S
Expert Rev Vaccines; 2013 Apr; 12(4):353-5. PubMed ID: 23560916
[TBL] [Abstract][Full Text] [Related]
4. Impact of human papillomavirus vaccination depends on effective vaccination strategy.
Lehtinen M; Paavonen J
Int J Cancer; 2009 Sep; 125(6):1490-1. PubMed ID: 19507251
[No Abstract] [Full Text] [Related]
5. Progress in the research on HPV vaccination: updates from the 25th International Papillomavirus Conference in Malmo, Sweden, 2009.
Bonanni P; Boccalini S; Bechini A
J Prev Med Hyg; 2009 Sep; 50(3):131-4. PubMed ID: 20499474
[No Abstract] [Full Text] [Related]
6. Characteristics of carcinogenic human papillomavirus infection in Suzhou: Epidemiology, vaccine evaluation, and associated diseases.
Li WJ; Xu HX; Chen ZH; Xu WD; Wu YJ
J Med Virol; 2017 May; 89(5):895-901. PubMed ID: 27696465
[TBL] [Abstract][Full Text] [Related]
7. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
Wheeler CM
Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
[No Abstract] [Full Text] [Related]
8. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
9. High-throughput monitoring of human papillomavirus type distribution.
Söderlund-Strand A; Dillner J
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):242-50. PubMed ID: 23221127
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
12. Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference.
Bosch FX; Rohan T; Schneider A; Frazer I; Pfister H; Castellsagué X; de Sanjosé S; Moreno V; Puig-Tintore LM; Smith PG; Muñoz N; zur Hausen H
J Clin Pathol; 2001 Mar; 54(3):163-75. PubMed ID: 11253126
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
Silling S; Kreuter A; Hellmich M; Swoboda J; Pfister H; Wieland U
J Clin Virol; 2012 Apr; 53(4):325-31. PubMed ID: 22261122
[TBL] [Abstract][Full Text] [Related]
14. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
Konopnicki D; Manigart Y; Gilles C; Barlow P; De Marchin J; Feoli F; Delforge M; Clumeck N; De Wit S
AIDS; 2016 Jan; 30(3):425-33. PubMed ID: 26765936
[TBL] [Abstract][Full Text] [Related]
15. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
[TBL] [Abstract][Full Text] [Related]
16. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
Schiffman M
Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the impact of human papillomavirus vaccines.
Chang Y; Brewer NT; Rinas AC; Schmitt K; Smith JS
Vaccine; 2009 Jul; 27(32):4355-62. PubMed ID: 19515467
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention.
Awolude OA; Morhason-Bello IO; Denny LA; Adewole IF
Vaccine; 2013 Dec; 31 Suppl 5():vii-x. PubMed ID: 24331751
[No Abstract] [Full Text] [Related]
19. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
20. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
Zhang L; Zhou F; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
